CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events.
about
Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac agingPPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease.PEG-albumin plasma expansion increases expression of MCP-1 evidencing increased circulatory wall shear stress: an experimental study.Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.Chemokine receptor CCR5: from AIDS to atherosclerosisIs PCOS an inflammatory process?Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture.Conditional deletion of cardiomyocyte peroxisome proliferator-activated receptor γ enhances myocardial ischemia-reperfusion injury in miceThe role of chemokines in recruitment of immune cells to the artery wall and adipose tissuePrognostic value of plasma biomarkers in patients with acute coronary syndrome: a review of advances in the past decade.CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular events.Cardiometabolic biomarkers are predictors of readmission and death in patients hospitalized for acute dyspnea.From multimarker approach to multiplex assays in acute coronary syndromes: what are we searching for?
P2860
Q30440919-74598B37-0989-4C96-A9B2-C8677DA5B7A9Q33576883-D912AB20-609F-4D83-B75B-8BEA918FCDD2Q34312170-6D2381FA-5C5E-475C-B4F2-E6FFD23ADBD5Q34430115-E27C7292-BB57-4324-BDE7-F9193006B7D1Q34672038-55CE8865-12FD-4C38-B6E4-ABB20675D62BQ35633277-531C77AE-43E0-47F5-BED9-D42BC6AC0404Q37486616-DCC57392-9B37-44B9-85A5-CC66E13FA70CQ37547865-DEDD07D5-148D-4401-BE46-FC07F064CB28Q37660659-2698EC9B-3457-40B2-A09F-D2B25069DE45Q38810989-0A5A9790-DDB8-4AA4-AB9F-2E6CD926C1EDQ38826694-55C337C0-F7C0-4530-85A6-BAD3192A801BQ39035199-45A3C770-15FD-444D-98A3-91047DDECA17Q39895236-72B3573F-8621-49F9-AE6F-9E53AC4B98E4
P2860
CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
CCL3 (MIP-1 alpha) levels are ...... er for future ischemic events.
@en
type
label
CCL3 (MIP-1 alpha) levels are ...... er for future ischemic events.
@en
prefLabel
CCL3 (MIP-1 alpha) levels are ...... er for future ischemic events.
@en
P2093
P1476
CCL3 (MIP-1 alpha) levels are ...... er for future ischemic events.
@en
P2093
Adriaan O Kraaijeveld
Bas L van der Hoeven
Berent J Prakken
Douwe E Atsma
Erik A L Biessen
Hein Putter
J Wouter Jukema
Martin J Schalij
Robert W Grauss
Saskia C A de Jager
P304
P356
10.1016/J.YJMCC.2008.06.003
P577
2008-06-21T00:00:00Z